Current Psychopharmacology
Title:Preface
Volume: 6
Author(s): Silvio Bellino*Maria Laura De Rosa
Affiliation:
- Centre for Personality Disorders, Department of Neuroscience University of Turin, Turin,Italy
Export Options
About this article
Cite this article as:
Bellino Silvio*, Rosa Laura De Maria, Preface, Current Psychopharmacology 2017; 6 (1) . https://dx.doi.org/10.2174/221155600601170405213718
DOI https://dx.doi.org/10.2174/221155600601170405213718 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Toll-Like Receptors and Inflammation in the CNS
Current Drug Targets - Inflammation & Allergy Novel Approach to the Role of NMDA Receptors in Traumatic Brain Injury
CNS & Neurological Disorders - Drug Targets Recent Technological Advances in the Mass Spectrometry-based Nanomedicine Studies: An Insight from Nanoproteomics
Current Pharmaceutical Design Brain Perfusion SPECT with Brodmann Areas Analysis in Differentiating Frontotemporal Dementia Subtypes
Current Alzheimer Research Editorial [Hot Topic: Novel Therapeutic Strategies in Neural Diseases Uncover Unexpected Disease Connections: From Neurodegeneration and Addiction to Pain and Depression (Guest Editor: Gonzalo Herradon)]
Current Pharmaceutical Design New Ways of Thinking and New Treatment Approaches
Adolescent Psychiatry Gyroxin and Its Biological Activity: Effects on CNS Basement Membranes and Endothelium and Protease-Activated Receptors
Current Medicinal Chemistry Helping Parents Promote Healthy and Safe Computer Habits
Adolescent Psychiatry Meet Our Editorial Board Member
Current Neuropharmacology Targeting mTOR Pathways in Human Malignancies
Current Pharmaceutical Design Quantum Molecular Dynamics, Topological, Group Theoretical and Graph Theoretical Studies of Protein-Protein Interactions
Current Topics in Medicinal Chemistry The Therapeutic Applications of Exosomes in Different Types of Diseases: A Review
Current Molecular Medicine The Targets of Curcumin
Current Drug Targets Fenofibrate, Homocysteine and Renal Function
Current Vascular Pharmacology Ameliorative Effect of Phosphodiesterase-5 Inhibitor in Rat Model of Vascular Dementia
Current Neurovascular Research Functional Autoradiography Shows Unaltered Cannabinoid CB1 Receptor Signalling in Hippocampus and Cortex of APP/PS1 Transgenic Mice
CNS & Neurological Disorders - Drug Targets α<sub>2</sub> Adrenoceptor: a Target for Neuropathic Pain Treatment
Mini-Reviews in Medicinal Chemistry Review of Antibiotic and Non-Antibiotic Properties of Beta-lactam Molecules
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Catatonia: A Brief Update
Current Psychiatry Reviews Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Current Drug Targets